Furthermore, in line with increased TNFα production, the increased presence of CD68 and MCP-1 are associated with the severity of NASH (Li et al., 2016; Diehl and Day, 2017). Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.